Over the past 3 months the biotech space is +30.4% and has only been outperformed by semiconductors, computer processing hardware and the computer peripherals industries. Additionally, the biotech sector is +13.6% in 2024, outdoing all of the major market averages handedly.
See the below breakdown of top performing biotech names in 2024:
Top 10 Biotech Stocks YTD
No. 10: Dianthus Therapeutics (DNTH) +144.8% YTD.
No. 9: Larimar Therapeutics (LRMR) +147.8% YTD.
No. 8: BiomX Inc (PHGE) +150% YTD.
No. 7: Mersana Therapeutics (MRSN) +155.5% YTD.
No. 6: Monopar Therapeutics (NASDAQ:MNPR) +184.7% YTD.
No. 5: Vera Therapeutics (NASDAQ:VERA) +204.4% YTD.
No. 4: Equillium (NASDAQ:EQ) +210.6% YTD.
No. 3: Ventyx Biosciences (VTYX) +244.7% YTD.
No. 2: Janux Therapeutics (JANX) +309.4% YTD.
No. 1: Elevation Oncology (NASDAQ:ELEV) +733.3% YTD.
For further analysis on the biotechnology industry, investors can look towards biotech focused exchange traded funds. See some popular funds listed below with each of their year-to-date performances.
More on Markets
- Cutting interest rates too soon could reverse progress on inflation: Powell to Congress (updated)
- Job openings roughly stable in January, quits rate edges down - JOLTS report
- Biggest stock movers today: TSM, JD, FL, CRWD, JWN, and more
- Is there an AI bubble? SA analysts weigh in
- ETFs add $56B in investor capital in February; ETF assets hit new record